Multiple corporates have helped staffing software provider Paradox close a $200m series C round, and electronic parts maker BOE Technology is putting up about $47m in a Chinese state-backed vehicle.

Chinese drug discovery platform QureBio raised corporate funding last week while JD.com and Qi-Anxin Technology Group were among the LPs that helped set up the $470m Shoudu Pan Healthcare Industry Fund.

Drug development platform creator Xbiome has raised nearly $100m in series B funding while bioindustrial startup services provider 21st.Bio secured a similar amount from Novo.

Cambridge spinout Gyroscope, which counts Fosun as an investor, is set to be picked up for a healthy premium on the projected valuation at which it failed to float in May.

Corporate-backed unicorns Via and Cohesity have both confidentially filed to go public while autonomous driving technology developer Haomo.AI raised nearly $157m.

Mobile wallet developer Momo grabbed $200m in a Mizuho Bank-led round valuing it above $2bn while silicon wafer producer Mieke pulled in $188m.

Data and analytics companies raise money in the hundreds of millions, while GV spreads investments across multiple sectors.

SoftBank invested in rounds for Olist, Open Co and Juspay while Innovaccer raised $150m.

Investments roll in for blockchain-based games, fintech, enterprise software and energy companies.

Innovent Biologics was among the investors in the oncology therapy developer’s oversubscribed round, which came as global investors are boosting their healthtech, biotech and wellness investment activities in China despite the country’s trade war with the US.